[Is there value in determining tumor markers in senology?].
Van Cauwenberge
J R
JR
Service de Gynécologie, Centre hospitalier du Bois de l'Abbaye de Seraing.
Collette
J
J
Franchimont
P
P
D000951:Antigens, Neoplasm / Q000302:isolation & purification; D001053:Apolipoproteins; D053399:Apolipoproteins D; D014408:Biomarkers, Tumor / Q000097:blood*; D001943:Breast Neoplasms / Q000097:blood* / Q000276:immunology; D002272:Carcinoembryonic Antigen / Q000302:isolation & purification; D002352:Carrier Proteins / Q000302:isolation & purification; D005260:Female; D006023:Glycoproteins; D006801:Humans; D026901:Membrane Transport Proteins; D018396:Mucin-1 / Q000302:isolation & purification; D009363:Neoplasm Proteins / Q000302:isolation & purification
C024328:APOD protein, human; D000951:Antigens, Neoplasm; D001053:Apolipoproteins; D053399:Apolipoproteins D; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D002352:Carrier Proteins; D006023:Glycoproteins; D026901:Membrane Transport Proteins; D018396:Mucin-1; D009363:Neoplasm Proteins
Y a-t-il intérêt à doser les marqueurs tumoraux en sénologie?